**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 62-44-2 |p-Acetophenetidide | 97 | 200-533-0 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T
Risk Phrases: 22 45
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful if swallowed. May cause cancer.Cancer suspect agent.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation. May cause skin sensitization, an allergic
reaction, which becomes evident upon re-exposure to this material.
May produce mucosal lesions.
Ingestion:
May cause irritation of the digestive tract. May cause kidney
damage. May cause central nervous system depression, characterized
by excitement, followed by headache, dizziness, drowsiness, and
nausea. Advanced stages may cause collapse, unconsciousness, coma
and possible death due to respiratory failure. Methemoglobinemia is
characterized by dizziness, drowsiness, headache, shortness of
breath, cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), rapid heart rate and chocolate-brown
colored blood. May cause sideroblastic anemia and hemolytic anemia.
May result in Stevens-Johnson syndrome. Ingestion of large amounts
may cause cyanosis (bluish discoloration of skin due to deficient
oxygenation of the blood), respiratory depression and cardiac
arrest.
Inhalation:
May cause respiratory tract irritation. May cause methemoglobinemia,
cyanosis (bluish discoloration of skin due to deficient oxygenation
of the blood), convulsions, tachycardia, dyspnea (labored breathing),
and death.
Chronic:
Chronic ingestion may cause effects similar to those of acute
ingestion. Chronic exposure may lead to weight loss, shortness of
breath, weakness, and often aplastic anemia. Experimental
carcinogen.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid
immediately.
Skin:
Flush skin with plenty of water for at least 15 minutes while
removing contaminated clothing and shoes. Get medical aid if
irritation develops or persists. Wash clothing before reuse.
Ingestion:
If victim is conscious and alert, give 2-4 cupfuls of milk or water.
Never give anything by mouth to an unconscious person. Get medical
aid immediately.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
In case of fire, use water, dry chemical, chemical foam, or
alcohol-resistant foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up or absorb material, then place into a
suitable clean, dry, closed container for disposal. Avoid generating
dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use with adequate ventilation.
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 62-44-2:
Russia: 0.5 mg/m3 TWA
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: white glistening crystals.
Odor: odorless
pH: Not available.
Vapor Pressure: < 1 mm Hg @25C
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 134-135C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: N/A
Explosion Limits, upper: N/A
Decomposition Temperature:
Solubility in water: 1g/90ml ether - soluble in glycerol
Specific Gravity/Density:
Molecular Formula: C10H13NO2
Molecular Weight: 179.22
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, dust generation.
Incompatibilities with Other Materials:
Strong oxidizing agents - strong acids - strong bases.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, carbon dioxide, nitrogen.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 62-44-2: AM4375000
LD50/LC50:
CAS# 62-44-2: Inhalation, mouse: LC50 = 33900 mg/m3; Oral, mouse:
LD50 = 866 mg/kg; Oral, rabbit: LD50 = 2500 mg/kg; Oral, rat: LD50 =
1650 mg/kg.
Carcinogenicity:
p-Acetophenetidide -
California: carcinogen, initial date 10/1/89
NTP: Suspect carcinogen
IARC: Group 2A carcinogen
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
USA RQ: CAS# 62-44-2: 100 lb final RQ; 45.4 kg final RQ
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 45 May cause cancer.
R 22 Harmful if swallowed.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 62-44-2: 1
Canada
CAS# 62-44-2 is listed on Canada's DSL List.
CAS# 62-44-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 62-44-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 10/16/1998 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Tetrahydropyran-2-Methanol, 98%
| 100-72-1 |
|
Molecular sieves, 4a, 8 to 12 mesh
| 70955-01-0 |
|
1-Chloro-4-nitrobenzene, 99%
| 100-00-5 |
|
L-Strychnine, 98%
| 57-24-9 |
|
2-Nitrophenylacetic acid, 99%
| 3740-52-1 |
|
3-Chlorothiophene-2-carboxylic acid, 99+%
| 59337-89-2 |
|
4-Biphenylacetic acid, 98%
| 5728-52-9 |
|
N,N-Diethylnipecotamide, Tech.
| 3367-95-1 |
|
2-Hydroxy-5-methylbenzophenone
| 1470-57-1 |
|
2-Chloro-4-nitrobenzoic acid, 98%
| 99-60-5 |
|
3-(3-(Trifluoromethyl)Phenoxy)Benzaldehyde 97%
| 78725-46-9 |
|
Ethylenediaminetetraacetic acid, tetrasodium salt, hydrate , 99%
| 64-02-8 |
|
3,4-Dinitrobenzoic acid, 99%
| 528-45-0 |
|
Methyltrichlorosilane, 98%
| 75-79-6 |
|
2,2'-Dinitrobiphenyl, 97%
| 2436-96-6 |
|
Phosphoric acid-d3, 85 wt % solution in D2O, 99+ atom % D
| 14335-33-2 |
|
2-Amino-3-Hydroxypyridine, 98%
| 16867-03-1 |
|
1,2,3-Trichloropropane, 99+ %
| 96-18-4 |
|
2-(Ethylamino)-1,3,4-Thiadiazole
| 13275-68-8 |
|
Triethyl 2-phosphonopropionate, 98%
| 3699-66-9 |
|
1,2,3-Tribromo-5-Fluorobenzene, 99+%
| 3925-78-8 |
|
1-Methylimidazole, 99%
| 616-47-7 |
|
(r,r)-chiraphos, 97%
| 74839-84-2 |
|
1-Acetyl-1-cyclohexene, 97%
| 932-66-1 |
|
4-Nitroindole, 98%
| 4769-97-5 |
|
N,N-Dimethylacetamide Dimethyl Acetal, Tech., 85%
| 7732-18-5 |
|
Benzimidazole, 98%
| 51-17-2 |
|
DL-O-Methoxy-Alpha-Methylbenzyl Alcohol, 99%
| 13513-82-1 |
|
2,4-Dichloro-6-nitrophenol moist solid containing 20% water
| 609-89-2 |
|
3-Acetyl-n-tosylpyrrole, 99+%
| |
|
1-(Pyrrolidino)-1-cyclohexene, 97%
| 1125-99-1 |
|
4-Chlororesorcinol, 98%
| 95-88-5 |
|
P-(Methylthio)Benzyl Alcohol, 98%
| 3446-90-0 |
|
2-Hydroxy-gamma-butyrolactone, 99%
| 19444-84-9 |
|
Ethyl 4-Methoxycarbonylbenzoylacetate
| 79322-76-2 |
|
2,2,6-Trimethyl-4H-1,3-dioxin-4-one, 97% (GC)
| 67-64-1 |
|
L-(+)-Cysteine, 99+% (TLC)
| 52-90-4 |
|
2-Methoxy-1,3-Dioxolane, 99%
| 19693-75-5 |
|
Z-Alpha,Beta-Dinitrostilbene 99.5+%
| 1796-05-0 |
|
N-Acetylglycine, 99%
| 543-24-8 |
|
p-Toluenesulfonic acid sodium salt, 99% (titr.)
| 657-84-1 |
|
Acridine orange, 80% (uv-vis)
| 65-61-2 |
|
2,2-Dichlorooctadecanal, 90%
| 119450-47-4 |
|
p-Acetophenetidide, 97%
| 62-44-2 |
|
Rhodium on carbon (5% rh)
| |
|
1,2,4-Benzenetriamine Dihydrochloride (Pract), 99% (titr.)
| 615-47-4 |
|
Ammonium hexafluoroniobate(v), 99.99%
| 12062-13-4 |
|
Nylon 6/6
| 32131-17-2 |
|
Aluminum fluoride monohydrate, 99.999%,
| 7784-18-1 |
|
2,4-Dinitrotoluene, 95%, remainder 2,6-dinitrotoluene
| 121-14-2 |
|
|